http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106937951-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 |
| filingDate | 2016-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106937951-B |
| titleOfInvention | The application of butylidenephthalide |
| abstract | It is a kind of to use an active constituent in the purposes for manufacturing a medicament, wherein the active constituent is selected from following group: butylidenephthalide (butylidenephthalide, BP), its pharmaceutically acceptable salt and combination above-mentioned, wherein the medicament is for preventing and/or treating oral submucosa fibrosis disease (oral submucous fibrosis, OSF) and can be used with the pattern of an injection, pastille, oral solution or liniment. |
| priorityDate | 2016-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.